An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement

Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of orthopaedic and trauma surgery 2014-03, Vol.134 (3), p.413-420
Hauptverfasser: Assmann, G., Kasch, R., Hofer, A., Schulz, A. P., Kayser, R., Lahm, A., Merk, H., Flessa, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 420
container_issue 3
container_start_page 413
container_title Archives of orthopaedic and trauma surgery
container_volume 134
creator Assmann, G.
Kasch, R.
Hofer, A.
Schulz, A. P.
Kayser, R.
Lahm, A.
Merk, H.
Flessa, S.
description Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system. Materials and methods Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective. Results The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned. Conclusion Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.
doi_str_mv 10.1007/s00402-014-1920-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500689517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261979824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</originalsourceid><addsrcrecordid>eNp1kU-LFDEQxYMo7uzqB_AiDV720m7lT3c63pbBdYWFveg5ZNLVTpbuTptKC3Pwu5thRgXBUxX1fu8F8hh7w-E9B9A3BKBA1MBVzY2AGp6xDVdS1dLw9jnbgJFt3UHDL9gl0RMAF52Bl-xCKKW16PSG_bydK_RxjlPwlZvdeKBAVRwqR7jkckv4I1CIc7UPS-VS3qe4jI7y4UO1daNfR5ePanEsRQ1urPaRlpDL4iNlqsJcMs5UjmUP025NhBPO-RV7MbiR8PV5XrGvdx-_bO_rh8dPn7e3D7WXWuRa7czODR1qIaBreuhlr2TrnBg6B8a1Azaq7VBqj21jUPWOY6t9I5uhQSm9vGLXp9wlxe8rUrZTII_j6GaMK1neALSdabgu6Lt_0Ke4pvIxZIVoudGmE6pQ_ET5FIkSDnZJYXLpYDnYYzf21I0t3dhjNxaK5-05ed1N2P9x_C6jAOIEUJHmb5j-Pv3_1F-o0Zuc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261979824</pqid></control><display><type>article</type><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</creator><creatorcontrib>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</creatorcontrib><description>Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system. Materials and methods Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective. Results The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned. Conclusion Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</description><identifier>ISSN: 0936-8051</identifier><identifier>EISSN: 1434-3916</identifier><identifier>DOI: 10.1007/s00402-014-1920-0</identifier><identifier>PMID: 24477287</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Arthroplasty, Replacement, Hip - adverse effects ; Arthroplasty, Replacement, Hip - economics ; Arthroplasty, Replacement, Hip - statistics &amp; numerical data ; Diagnosis-Related Groups - economics ; Economic analysis ; Female ; Germany ; Hip Arthroplasty ; Hospital Costs ; Humans ; Insurance, Health, Reimbursement - economics ; Joint Prosthesis - adverse effects ; Joint Prosthesis - economics ; Joint surgery ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Orthopedics ; Prosthesis Failure ; Reoperation - economics ; Retrospective Studies</subject><ispartof>Archives of orthopaedic and trauma surgery, 2014-03, Vol.134 (3), p.413-420</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>Archives of Orthopaedic and Trauma Surgery is a copyright of Springer, (2014). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</citedby><cites>FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00402-014-1920-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00402-014-1920-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24477287$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Assmann, G.</creatorcontrib><creatorcontrib>Kasch, R.</creatorcontrib><creatorcontrib>Hofer, A.</creatorcontrib><creatorcontrib>Schulz, A. P.</creatorcontrib><creatorcontrib>Kayser, R.</creatorcontrib><creatorcontrib>Lahm, A.</creatorcontrib><creatorcontrib>Merk, H.</creatorcontrib><creatorcontrib>Flessa, S.</creatorcontrib><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><title>Archives of orthopaedic and trauma surgery</title><addtitle>Arch Orthop Trauma Surg</addtitle><addtitle>Arch Orthop Trauma Surg</addtitle><description>Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system. Materials and methods Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective. Results The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned. Conclusion Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arthroplasty, Replacement, Hip - adverse effects</subject><subject>Arthroplasty, Replacement, Hip - economics</subject><subject>Arthroplasty, Replacement, Hip - statistics &amp; numerical data</subject><subject>Diagnosis-Related Groups - economics</subject><subject>Economic analysis</subject><subject>Female</subject><subject>Germany</subject><subject>Hip Arthroplasty</subject><subject>Hospital Costs</subject><subject>Humans</subject><subject>Insurance, Health, Reimbursement - economics</subject><subject>Joint Prosthesis - adverse effects</subject><subject>Joint Prosthesis - economics</subject><subject>Joint surgery</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Orthopedics</subject><subject>Prosthesis Failure</subject><subject>Reoperation - economics</subject><subject>Retrospective Studies</subject><issn>0936-8051</issn><issn>1434-3916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU-LFDEQxYMo7uzqB_AiDV720m7lT3c63pbBdYWFveg5ZNLVTpbuTptKC3Pwu5thRgXBUxX1fu8F8hh7w-E9B9A3BKBA1MBVzY2AGp6xDVdS1dLw9jnbgJFt3UHDL9gl0RMAF52Bl-xCKKW16PSG_bydK_RxjlPwlZvdeKBAVRwqR7jkckv4I1CIc7UPS-VS3qe4jI7y4UO1daNfR5ePanEsRQ1urPaRlpDL4iNlqsJcMs5UjmUP025NhBPO-RV7MbiR8PV5XrGvdx-_bO_rh8dPn7e3D7WXWuRa7czODR1qIaBreuhlr2TrnBg6B8a1Azaq7VBqj21jUPWOY6t9I5uhQSm9vGLXp9wlxe8rUrZTII_j6GaMK1neALSdabgu6Lt_0Ke4pvIxZIVoudGmE6pQ_ET5FIkSDnZJYXLpYDnYYzf21I0t3dhjNxaK5-05ed1N2P9x_C6jAOIEUJHmb5j-Pv3_1F-o0Zuc</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Assmann, G.</creator><creator>Kasch, R.</creator><creator>Hofer, A.</creator><creator>Schulz, A. P.</creator><creator>Kayser, R.</creator><creator>Lahm, A.</creator><creator>Merk, H.</creator><creator>Flessa, S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</title><author>Assmann, G. ; Kasch, R. ; Hofer, A. ; Schulz, A. P. ; Kayser, R. ; Lahm, A. ; Merk, H. ; Flessa, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-4b9baf8e722085d0d3d436aa2f8a09a6fe5468e37ce659e4da1e67c535f5e33c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arthroplasty, Replacement, Hip - adverse effects</topic><topic>Arthroplasty, Replacement, Hip - economics</topic><topic>Arthroplasty, Replacement, Hip - statistics &amp; numerical data</topic><topic>Diagnosis-Related Groups - economics</topic><topic>Economic analysis</topic><topic>Female</topic><topic>Germany</topic><topic>Hip Arthroplasty</topic><topic>Hospital Costs</topic><topic>Humans</topic><topic>Insurance, Health, Reimbursement - economics</topic><topic>Joint Prosthesis - adverse effects</topic><topic>Joint Prosthesis - economics</topic><topic>Joint surgery</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Orthopedics</topic><topic>Prosthesis Failure</topic><topic>Reoperation - economics</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Assmann, G.</creatorcontrib><creatorcontrib>Kasch, R.</creatorcontrib><creatorcontrib>Hofer, A.</creatorcontrib><creatorcontrib>Schulz, A. P.</creatorcontrib><creatorcontrib>Kayser, R.</creatorcontrib><creatorcontrib>Lahm, A.</creatorcontrib><creatorcontrib>Merk, H.</creatorcontrib><creatorcontrib>Flessa, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of orthopaedic and trauma surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assmann, G.</au><au>Kasch, R.</au><au>Hofer, A.</au><au>Schulz, A. P.</au><au>Kayser, R.</au><au>Lahm, A.</au><au>Merk, H.</au><au>Flessa, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement</atitle><jtitle>Archives of orthopaedic and trauma surgery</jtitle><stitle>Arch Orthop Trauma Surg</stitle><addtitle>Arch Orthop Trauma Surg</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>134</volume><issue>3</issue><spage>413</spage><epage>420</epage><pages>413-420</pages><issn>0936-8051</issn><eissn>1434-3916</eissn><abstract>Introduction Aseptic loosening is one of the most common intermediate and long-term complications after total hip replacement (THR). These complications cause suffering and require expensive revision surgery. Little concrete data on direct costs are available from the hospital’s, moreover operating department’s perspective. We here provide a detailed analysis of the costs of THR revision and relate them to reimbursement underlying the German diagnosis-related groups (DRG) system. Materials and methods Major cost parameters were identified using for orientation the cost matrix of the German Institute for Hospital Reimbursement (InEK GmbH). We then retrospectively analysed the major direct costs of aseptic revision THR in terms of contribution margins I and II. The analysis included a total of 114 patients who underwent aseptic revision from 1 January 2009 to 31 March 2012. Data were retrieved from the hospital information system and patient records. All costs of surgery, diagnostic tests, and other treatments were calculated as purchase prices in EUR. The comparative analysis of direct costs and reimbursements was done for DRG I46A and I46B from the hospital’s, especially treating department’s rather than the society or healthcare insurance’s perspective. Results The average direct cost incurred by the hospital for a THR revision was €4,380.0. The largest share was accounted for surgical costs (62.7 % of total). Implant and staff costs were identified as the most important factors that can be influenced. The proportion of the daily contribution margin that was left to cover the hospital’s indirect cost decreased with the relative cost weight of the DRG to which a patient was assigned. Conclusion Our study for the first time provides a detailed analysis of the major direct case costs of THR revision for aseptic loosening from the provider’s perspective. Our findings suggest that these revision operations could be performed cost-beneficially by the operating unit. From an economic perspective, cases with higher cost weights are more favorable for a hospital. These results need to be confirmed in multicenter studies.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24477287</pmid><doi>10.1007/s00402-014-1920-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0936-8051
ispartof Archives of orthopaedic and trauma surgery, 2014-03, Vol.134 (3), p.413-420
issn 0936-8051
1434-3916
language eng
recordid cdi_proquest_miscellaneous_1500689517
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Aged
Aged, 80 and over
Arthroplasty, Replacement, Hip - adverse effects
Arthroplasty, Replacement, Hip - economics
Arthroplasty, Replacement, Hip - statistics & numerical data
Diagnosis-Related Groups - economics
Economic analysis
Female
Germany
Hip Arthroplasty
Hospital Costs
Humans
Insurance, Health, Reimbursement - economics
Joint Prosthesis - adverse effects
Joint Prosthesis - economics
Joint surgery
Male
Medicine
Medicine & Public Health
Middle Aged
Orthopedics
Prosthesis Failure
Reoperation - economics
Retrospective Studies
title An economic analysis of aseptic revision hip arthroplasty: Calculation of partial hospital costs in relation to reimbursement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A23%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20economic%20analysis%20of%20aseptic%20revision%20hip%20arthroplasty:%20Calculation%20of%20partial%20hospital%20costs%20in%20relation%20to%20reimbursement&rft.jtitle=Archives%20of%20orthopaedic%20and%20trauma%20surgery&rft.au=Assmann,%20G.&rft.date=2014-03-01&rft.volume=134&rft.issue=3&rft.spage=413&rft.epage=420&rft.pages=413-420&rft.issn=0936-8051&rft.eissn=1434-3916&rft_id=info:doi/10.1007/s00402-014-1920-0&rft_dat=%3Cproquest_cross%3E2261979824%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261979824&rft_id=info:pmid/24477287&rfr_iscdi=true